378 related articles for article (PubMed ID: 18226134)
41. The effect of oral versus vaginal misoprostol on cervical dilatation in first-trimester abortion: a double-blind, randomized study.
Inal MM; Ertopçu K; Arici A; Ozelmas I
Eur J Contracept Reprod Health Care; 2003 Dec; 8(4):197-202. PubMed ID: 15006266
[TBL] [Abstract][Full Text] [Related]
42. A comparison of vaginal misoprostol 800 microg versus 400 microg for anembryonic pregnancy: a randomized comparative trial.
Srikhao N; Tannirandorn Y
J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S41-7. PubMed ID: 17722316
[TBL] [Abstract][Full Text] [Related]
43. Therapeutic termination of second trimester pregnancy with vaginal misoprostol.
Pongsatha S; Tongsong T; Suwannawut O
J Med Assoc Thai; 2001 Apr; 84(4):515-9. PubMed ID: 11460962
[TBL] [Abstract][Full Text] [Related]
44. Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion.
Kapp N; Borgatta L; Ellis SC; Stubblefield P
Contraception; 2006 May; 73(5):525-7. PubMed ID: 16627039
[TBL] [Abstract][Full Text] [Related]
45. Second trimester pregnancy termination with 800 mcg vaginal misoprostol.
Pongsatha S; Tongsong T
J Med Assoc Thai; 2001 Jun; 84(6):859-63. PubMed ID: 11556466
[TBL] [Abstract][Full Text] [Related]
46. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
Chawdhary R; Rana A; Pradhan N
J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
[TBL] [Abstract][Full Text] [Related]
47. The effect of vaginal pH on labor induction with vaginal misoprostol.
Chandra S; Allen V; Lee W; Fanning C; Young D
J Matern Fetal Neonatal Med; 2005 Jun; 17(6):387-91. PubMed ID: 16009641
[TBL] [Abstract][Full Text] [Related]
48. Pregnancy termination using vaginal misoprostol in women with more than one caesarean section.
Daponte A; Nzewenga G; Dimopoulos KD; Guidozzi F
J Obstet Gynaecol; 2007 Aug; 27(6):597-600. PubMed ID: 17896259
[TBL] [Abstract][Full Text] [Related]
49. The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13-22 weeks gestation.
Fiala C; Swahn ML; Stephansson O; Gemzell-Danielsson K
Hum Reprod; 2005 Nov; 20(11):3072-7. PubMed ID: 16055455
[TBL] [Abstract][Full Text] [Related]
50. Second-trimester pregnancy termination: comparison of three different methods.
Makhlouf AM; Al-Hussaini TK; Habib DM; Makarem MH
J Obstet Gynaecol; 2003 Jul; 23(4):407-11. PubMed ID: 12881083
[TBL] [Abstract][Full Text] [Related]
51. A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12-20 weeks gestation.
Tang OS; Chan CC; Kan AS; Ho PC
Hum Reprod; 2005 Nov; 20(11):3062-6. PubMed ID: 16037110
[TBL] [Abstract][Full Text] [Related]
52. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
[TBL] [Abstract][Full Text] [Related]
53. A randomized comparison of sublingual and vaginal misoprostol for cervical priming before suction termination of first-trimester pregnancy.
Vimala N; Mittal S; Kumar S; Dadhwal V; Sharma Y
Contraception; 2004 Aug; 70(2):117-20. PubMed ID: 15288215
[TBL] [Abstract][Full Text] [Related]
54. Vaginal misoprostol vs. concentrated oxytocin plus low-dose prostaglandin E2 for second trimester pregnancy termination.
Owen J; Hauth JC
J Matern Fetal Med; 1999; 8(2):48-50. PubMed ID: 10090490
[TBL] [Abstract][Full Text] [Related]
55. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
Guest J; Chien PF; Thomson MA; Kosseim ML
BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
[TBL] [Abstract][Full Text] [Related]
56. Effect of bacterial vaginosis on the pharmacokinetics of misoprostol in early pregnancy.
Sioutas A; Sandström A; Fiala C; Watzer B; Schweer H; Gemzell-Danielsson K
Hum Reprod; 2012 Feb; 27(2):388-93. PubMed ID: 22128294
[TBL] [Abstract][Full Text] [Related]
57. Oral versus self-administered vaginal misoprostol at home before surgical termination of pregnancy: a randomised controlled trial.
Oppegaard KS; Qvigstad E; Nesheim BI
BJOG; 2006 Jan; 113(1):58-64. PubMed ID: 16398773
[TBL] [Abstract][Full Text] [Related]
58. Labor induction abortion utilizing trilostane, a 3beta-hydroxysteroid dehydrogenase inhibitor.
le Roux PA; van der Spuy ZM
Contraception; 2005 May; 71(5):343-7. PubMed ID: 15854634
[TBL] [Abstract][Full Text] [Related]
59. Misoprostol administered by epithelial routes: Drug absorption and uterine response.
Meckstroth KR; Whitaker AK; Bertisch S; Goldberg AB; Darney PD
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):582-90. PubMed ID: 16946218
[TBL] [Abstract][Full Text] [Related]
60. Sublingual versus vaginal misoprostol for cervical ripening PRIOR TO manual vacuum aspiration under local anaesthesia: a randomized study.
Caliskan E; Filiz T; Yucesoy G; Coskun E; Vural B; Corakci A
Eur J Contracept Reprod Health Care; 2007 Dec; 12(4):372-7. PubMed ID: 17853158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
